STAT

JULY 7, 2023

Jonathan Studnek knows some people imagine that driving an ambulance at high speed with lights flashing and sirens wailing — racing through messily parted traffic to the scene of a crisis — is the best part of being an emergency medic. For him, that couldn’t be further from the truth. “If you’ve been in the industry for any length, you know innately: When you’re in the front of an ambulance and the lights are on, that’s the most dangerous situatio

Hospitals 308

Hospitals 308

PharmaVoice

JULY 7, 2023

Leqembi’s U.S. approval is a milestone in Alzheimer’s research and medicine — and there are a few other late-stage biologic drugs that could follow.

246

246

Pharma Times

JULY 3, 2023

Project aims to boost the adoption of technology across London’s NHS and help patients manage conditions - News - PharmaTimes

153

153

BioPharma Dive

JULY 6, 2023

Five years after helping launch Allogene Therapeutics, Pfizer is backing another developer of “off-the-shelf” cell therapies in a deal that gives the drugmaker the chance to acquire a multiple myeloma treatment.

130

130

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

JULY 3, 2023

When the U.S. Supreme Court released its landmark ruling overturning the use of race-conscious college admissions, LaShyra Nolen was on clinical rotation. For Nolen, a fourth-year medical student at Harvard Medical School, the news sent a chill down her spine even though she had been anticipating it. “It felt very lonely,” said Nolen, who is Black and the first in her family to get a bachelors of science degree and attend medical school.

Medical Schools 285

Medical Schools 285

PharmaVoice

JULY 6, 2023

New lawsuits challenging the Inflation Reduction Act’s price negotiation program hit the government with multiple Constitution-based challenges.

246

246

BioPharma Dive

JULY 5, 2023

Phase 2 results show a pill the company is developing is competitive with other oral medicines in testing against psoriasis, among them the TYK2 inhibitors that have drawn significant industry interest.

109

109

STAT

JULY 5, 2023

WASHINGTON – Novo Nordisk spent $11 million on meals and travel for thousands of doctors last year, federal records show, as part of its push to promote Ozempic and other weight loss-inducing diabetes drugs. The pharmaceutical company bought more than 457,000 meals to educate doctors and other prescribers about its portfolio of drugs known as GLP-1 agonists, according to the newly released data from the Centers for Medicare and Medicaid Services.

Diabetes 263

Diabetes Pharmaceutical Companies Pharmaceutical Companies 263

PharmaVoice

JULY 5, 2023

NK3 receptor antagonists offer a new option, but experts say more are needed.

147

147

PharmExec

JULY 5, 2023

Rose Blackburne, MD, MBA, vice president, global head, general medicine, PPD Clinical Research, Thermo Fisher Scientific, discusses health equity in pharma, specifically racial biases, and how the industry can address inequities in access and care going forward.

105

105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharmacy Joe

JULY 1, 2023

In this episode, I’ll discuss the role for ketamine in status epilepticus. Episode 831: What is the role for ketamine in refractory status epilepticus? Subscribe on iTunes , Android , or Stitcher The initial therapy for status epilepticus is to use one of the following benzodiazepines: Lorazepam 0.1 mg/kg capped at 4 mg IV Midazolam 0.2 mg/kg capped at 10 mg IM Diazepam 0.15 mg/kg capped at 10 mg IV But what happens if the patient does not respond to this initial therapy?

Inpatient 105

Inpatient 105

STAT

JULY 3, 2023

DENVER — The founder of Field Trip , a chain of shuttered ketamine clinics currently facing insolvency, put forward an unexpected theory of how psychedelics work to treat depression last month. “The truth is, almost all of the effect of psychedelic-assisted therapy could be placebo,” said Ronan Levy, speaking at a five-day conference on the emerging field of psychedelic medicine.

254

254

Pharmaceutical Technology

JULY 3, 2023

Pipeline developments within the obesity space have recently garnered interest following recent results published on Eli Lilly’s retatrutide.

119

119

Outsourcing Pharma

JULY 5, 2023

Lucy Jung is the CEO and founder at Charco Neurotech, a medtech start-up which has developed the CEU1, a non-invasive wearable device for Parkinson's, that uses vibrotactile stimulation to reduce symptoms of slowness and stiffness resulting in improved movement. We spoke to her about her background, how she got involved in the Parkinson's space and her fascination for problem-solving.

105

105

The Honest Apothecary

JULY 4, 2023

Jeremy, an HR business partner to the nursing staff of a medium sized community hospital, arrived at his desk at 8:30am on Monday to a familiar sight. There, sitting on his desk, was yet another resignation letter from a nurse on the 7th floor. Tina’s floor. Over the past 6 months Jeremy had 5 such letters reach his desk. Each one a subtle reminder to him that his organization is dealing face-to-face with the problem with toxic leadership in healthcare. “I regret to inform you that m

Hospitals 100

Hospitals Communication 100

STAT

JULY 6, 2023

Traumatic brain injury multiplies the risk of major depression eightfold. While the emotional trauma of whatever caused such deep damage may be understandable, from a blast in a war zone to a blow on the playing field, there’s a physiological component, too, that neuroscientists have long suspected but have been unable to identify. “As clinicians, a lot of us had a gut feeling that [TBI-associated depression] is a different disease,” said Shan Siddiqi, a Harvard Medical Scho

Medical Schools 252

Medical Schools Hospitals 252

PharmExec

JULY 7, 2023

Through the power of large language models and generative AI, pharma and biotech companies are transforming medical information delivery by offering direct, trustworthy, and accurate answers to patients and healthcare providers, significantly reducing time and frustration.

98

98

Pharmaceutical Technology

JULY 4, 2023

While drug shortages have been a major cause for concern over the past few years, medications to treat cancer are in particularly short supply.

111

111

Drug Patent Watch

JULY 2, 2023

Annual Drug Patent Expirations for LEVITRA Levitra is a drug marketed by Bayer Hlthcare and is included in one NDA. There are two patents protecting this drug and three Paragraph… The post New patent expiration for Bayer Hlthcare drug LEVITRA appeared first on DrugPatentWatch - Make Better Decisions.

98

98

STAT

JULY 6, 2023

The Food and Drug Administration on Thursday granted full approval to the first therapy for Alzheimer’s disease clearly shown to slow the cognitive decline associated with the disease — a milestone in treatment, even if the benefits are modest. The drug, called Leqembi , was developed by Eisai , the Japanese pharmaceutical company, and sold in partnership with Biogen.

Pharmaceutical Companies 252

Pharmaceutical Companies Pharmaceutical Companies 252

PharmExec

JULY 6, 2023

Senior editor Fran Pollaro chats with Sharlene Jenner, vice president of engagement strategy, Abelson Taylor about the transformative impact and ethical considerations of AI in the pharmaceutical industry, emphasizing its potential in data analysis and marketing, while also highlighting the pioneering work of AI companies in advancing drug discovery.

98

98

The Pharmacist

JULY 7, 2023

With a recent study in the BMJ suggesting an increased risk of dementia in those using hormone replacement therapy (HRT), should women now peel off their patches? Rod Tucker investigates, in the first in a Review series of articles for the Pharmacist. The menopause represents a normal physiological change that occurs on average in women […] The post HRT and the risk of dementia: Should users be worried?

98

98

Pharma Times

JULY 7, 2023

Second dose of treatment generates response among young people during Oxford University trial - News - PharmaTimes

Immunity 117

Immunity Immunization Vaccines 117

STAT

JULY 7, 2023

As part of the Biden administration’s broader efforts to lower health care costs, the White House announced new guidelines on Friday targeting a few of the most common sources of sticker shock. The new policy initiatives target some of the usual suspects: surprise billing , which was restricted in 2020 yet persists as health care providers exploit loopholes ; short-term insurance policies that often fail to cover essential treatment; and high-interest credit cards and payment plans especi

Hospitals 248

Hospitals 248

PharmExec

JULY 7, 2023

While large pharma investment in biotechs is down—as pharmas become more strategic in their selections—it is scarcely out, with the partnership dynamic between the two sides remaining strong.

97

97

The Pharmacist

JULY 5, 2023

The UK Health Security Agency (UKHSA) was set up with financial controls ‘so poor’ that it cannot establish whether its transactions were in line with its purpose as laid out by parliament. This meant that the UKHSA’s £3.3bn worth of inventory transferred from NHS Test and Trace could not be verified by proper financial records. […] The post Probe into UKHSA finds weak financial controls and 'alarming' lack of pandemic planning appeared first on The Pharmacist.

98

98

Outsourcing Pharma

JULY 4, 2023

Drugs like Annovis Bioâs buntanetap and prasinezumab have the potential to ârevolutionize the treatment of Parkinsonâs Diseaseâ says analytics company, GlobalData, an analytics company, but it is a complex road ahead.

111

111

STAT

JULY 7, 2023

The recent FDA approval of Leqembi , the latest anti-amyloid drug, is undoubtedly a breakthrough for the field, providing a new way to slow the advancement of mild cognitive impairment or early-stage Alzheimer’s disease. As a practicing geriatrician who has treated Alzheimer’s patients for more than 40 years and the co-founder and chief science officer at the Alzheimer’s Drug Discovery Foundation, I have never been more optimistic about our potential to transform how we trea

247

247

Pharma Times

JULY 4, 2023

Therapy has been developed to reduce the frequency, duration and severity of migraine attacks - News - PharmaTimes

115

115

The Pharmacist

JULY 6, 2023

The community pharmacy sector can help design a solution to the needs of the health service if NHS England and the Department of Health and Social Care (DHSC) set out a clear vision for what they want, and how they are going to pay for it, the chief executive of the Company Chemists’ Association (CCA) […] The post CCA chief: NHS and DHSC must decide what they want – and how they will pay for it appeared first on The Pharmacist.

Community Pharmacies 96

Community Pharmacies 96

European Pharmaceutical Review

JULY 4, 2023

The International Organization for Standardization (ISO) has published its new standard Sterilization of health care products — Microbiological methods — Part 3 Bacterial endotoxin testing ( ISO 11737-3:2023). The document contains requirements and guidance for testing for bacterial endotoxins. This includes products that must be non-pyrogenic based on either intended use or non-pyrogenic label claim, or both.

Documentation 96

Documentation Labelling 96

STAT

JULY 6, 2023

When then-Vice President Biden launched the Cancer Moonshot in 2016, there was reason to be optimistic. Decades of rigorous science had transformed many cancers from a death sentence to a manageable chronic disease. New treatment advances — including gene and cell therapies and immunotherapies — were showing stunning results. With support from the biopharmaceutical industry and the help of smart government policies, ending cancer was, and is, an achievable goal.

246

246

The Honest Apothecary

JULY 1, 2023

In the realm of talent acquisition, the pivotal role of the interviewing process in selecting the right candidates cannot be overstated. After all, it is during these crucial interactions that potential employees showcase their skills, experience, and cultural fit. However, as acclaimed author and business leader Stephen Covey once wisely remarked, “Hire for character, train for skill.” This quote encapsulates a fundamental truth.

94

94

The Pharmacist

JULY 5, 2023

Pharmacist degree apprenticeships are being considered as part of NHS England’s plan to increase the workforce. In the NHS Long Term Workforce Plan, published last week (30 June), NHS England (NHSE) said there was potential for pharmacy technicians to undertake expanded training via apprenticeships, and that consideration was being given to the potential of […] The post More detail on proposed pharmacist apprenticeships needed appeared first on The Pharmacist.

Pharmacy Technician 95

Pharmacy Technician 95

European Pharmaceutical Review

JULY 7, 2023

Scientists have created paracetamol and ibuprofen, two of the world’s most common painkillers, out of turpentine (β-pinene), a compound found in pine trees. Turpentine is also a waste product from the paper industry. According to the research published in the journal ChemSusChem , the quantity of this waste generated worldwide is enough to supply the global demand for paracetamol and ibuprofen.

Compounding 94

Compounding 94